Cancer Detection and Diagnosis Research in Washington
Cancer Detection and Diagnosis Research (93.394) awarded $169 million to recipients in Washington in 93 grants from fiscal 2021 to 2025, 6.3% of the program's national total. Fred Hutchinson Cancer Center received the most, $96.7 million.
- Awarded in Washington$169 million
- Awards93
- Share of the program6.3%
- Rank among states6th of 45
- National total$2.7 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 50 | $27.6 million |
| FY 2022 | 48 | $30.2 million |
| FY 2023 | 52 | $38.7 million |
| FY 2024 | 48 | $36.4 million |
| FY 2025 | 43 | $36.6 million |
Recipients in Washington
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Fred Hutchinson Cancer Center | Nonprofits | 37 | $96.7 million |
| University of Washington | Colleges and universities | 22 | $34.2 million |
| Battelle Memorial Institute | Nonprofits | 3 | $8.2 million |
| Institute for Systems Biology | Nonprofits | 5 | $7.2 million |
| Phase Genomics Inc | Small businesses | 2 | $4.0 million |
| Twinstrand Biosciences Inc | Small businesses | 1 | $4.0 million |
| Alpenglow Biosciences, Inc. | Small businesses | 2 | $2.4 million |
| Seattle Children's Hospital | Nonprofits | 3 | $2.2 million |
| Veravanti Inc. | Small businesses | 1 | $2.0 million |
| Washington State University | Colleges and universities | 4 | $1.6 million |
Open opportunities under this program
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 50 on the program page
Questions people ask
How much Cancer Detection and Diagnosis Research money goes to Washington?
$169 million from fiscal 2021 to 2025, across 93 awards. Washington ranks 6th of 45 states and territories for this program.
Who receives Cancer Detection and Diagnosis Research money in Washington?
The largest recipient is Fred Hutchinson Cancer Center, with $96.7 million in 37 awards. Next are University of Washington and Battelle Memorial Institute.
Can organizations in Washington apply now?
Yes, 50 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Detection and Diagnosis Research in other states
Other large programs in Washington
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Federal Transit Formula Grants
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Temporary Assistance for Needy Families
- National School Lunch Program
- Federal Transit Capital Investment Grants
- Allergy and Infectious Diseases Research
- Child Care and Development Block Grant